A PHASE II/III RANDOMIZED CLINICAL TRIAL TO STUDY THE EFFICACY AND SAFETY OF THE COMBINATION REGIMEN OF MK-5172 AND MK-8742 IN SUBJECTS WITH CHRONIC HEPATITIS C VIRUS INFECTION AND CHRONIC KIDNEY DISEASE
- Registry ID
- 052-00
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Study type
- INTERVENTIONAL
- Sponsor
- MERCK CANADA INC
- Start date
- 2014-07-10
- Last update
- 2014-02-26
Conditions
- KIDNEY DISEASE
- HEPATITIS C VIRUS
Related clinical trials
- PODOMOUNT-BASKET, A PHASE II, MULTICENTRE, RANDOMISED, 2-ARM PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED BASKET TRIAL TO ASSESS SAFETY, TOLERABILITY, PK, AND EFFICACY OF BI 764198 IN FOUR PROTEINURIC KIDNEY DISEASES
- A PHASE 2A, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF VX-407 IN SUBJECTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE WHO HAVE A SUBSET OF PKD1 GENE VARIANTS
- PHASE 3, RANDOMIZED, CONTROLLED, OPEN-LABEL STUDY TO COMPARE THE EFFICACY AND SAFETY OF BEMNIFOSBUVIR-RUZASVIR FIXED-DOSE COMBINATION (BEM/RZR FDC) VERSUS SOFOSBUVIR-VELPATASVIR FIXED-DOSE COMBINATION (SOF/VEL FDC) IN SUBJECTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION
- BLEEDING REDUCTION IN ACUTE AND CHRONIC KIDNEY PATIENTS HAVING SURGERY
(BRACKETS) PILOT TRIAL
- A PHASE IIB, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, DOSE-FINDING STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF BALCINRENONE IN COMBINATION WITH DAPAGLIFLOZIN COMPARED WITH DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ALBUMINURIA
- CANAGLIFLOZIN IN PATIENTS WITH ADVANCED RENAL DISEASE WITH MRI ENDPOINTS (CARE-MRI TRIAL)
View on source registry